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Microbial infection primes a CD8+ cytotoxic T cell response that gives rise to a long-lived
population of circulating memory cells able to provide protection against systemic
reinfection. Despite this, effective CD8+ T cell surveillance of barrier tissues such as skin
and mucosa typically wanes with time, resulting in limited T cell-mediated protection in
these peripheral tissues. However, recent evidence suggests that a specialized subset
of CD103+ memory T cells can permanently lodge and persist in peripheral tissues,
and that these cells can compensate for the loss of peripheral immune surveillance by
circulating memory T cells. Here, we review evolving concepts regarding the generation
and long-term persistence of these tissue-resident memory T cells (TRM) in epithelial and
neuronal tissues. We further discuss the role of TRM cells in local infection control and
their contribution to localized immune phenomena, in both mice and humans.
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INTRODUCTION
Primary infection results in immunity against reencounter with
the same pathogen. This anamnestic “immune memory” builds
the conceptual basis for vaccination and relies on different
types of adaptive memory cells including B cells and T cells
(Welsh et al., 2004). While almost all current vaccines target
B cells for the induction of antibody-mediated immunity, this
approach has significant limitations for a number of infectious
diseases including AIDS, tuberculosis, and malaria (Seder and
Hill, 2000). The relative inefficiency of humoral immunity in
these cases is related to various evasion strategies employed by
the pathogens, including their rapid variation of exposed antigens
and their intracellular localization. In addition, serum antibod-
ies have only limited access to some epithelial compartments
under non-inflammatory conditions and as a consequence, may
fail to provide the heightened level of immediate immune control
required to prevent the establishment and persistence of periph-
eral infections (Zinkernagel, 2002). Thus, protection from certain
pathogens relies on potent T cell-dependent cellular immune
responses (Seder and Hill, 2000). Understanding the generation
and maintenance of such T cell responses, particularly those in
barrier locations at body surfaces, is of critical importance for the
development of future vaccines.
CIRCULATING CD8+ MEMORY T CELLS
The activation of pathogen-specific T cells in lymphoid tissues
draining the site of infection results in the generation of a large
pool of effector cells (Jameson and Masopust, 2009). During
activation, these cells acquire the expression of certain migra-
tion receptors that allow them to infiltrate peripheral tissues
where they contribute to pathogen clearance through the elimi-
nation of infected cells and the release of proinflammatory and
microbicidal mediators (Harty et al., 2000; Nolz et al., 2011).
Interestingly, the organ-specific microenvironments in lymphoid
tissues can preferentially support the induction of migration
receptors required for T cell entry specifically into those tissues
that are connected to the respective lymphoid priming sites
(Agace, 2006; Nolz et al., 2011). Such organ-specific migra-
tion imprinting is best documented for barrier tissues such as
skin and gut and involves the induction of ligands for E- and
P-selectin as well as the integrin α4β7 and the chemokine recep-
tor CCR9, respectively (Parrott et al., 1976; Guy-Grand et al.,
1978; Campbell and Butcher, 2002; Mora et al., 2005; Agace, 2006;
Nolz et al., 2011). It should be noted, however, that migration
imprinting is by no means absolute and that substantial numbers
of effector CD8+ T cells disperse into a broad variety of peripheral
tissues even after localized peripheral infections (Marshall et al.,
2001; Masopust et al., 2004).
While the vast majority of effector cells disappear from
the circulation following pathogen clearance, there remains a
heterogeneous population of long-lived memory cells capa-
ble of mounting rapid recall responses on antigen reencounter
(Jameson and Masopust, 2009). Memory T cells are commonly
grouped into two major subsets based on their functional status
and expression of certain homing receptors: (1) central memory
T cells (TCM) that express the lymph node-targeting molecules
CD62L and CCR7, and (2) effector memory T cells (TEM) that
largely lack these receptors, but instead express certain migration
molecules that target them to peripheral non-lymphoid tissues
(Sallusto et al., 1999, 2004). This delineation between the two
subsets, as initially defined for human blood cells (Sallusto et al.,
1999), is now also widely used to define migratory abilities and
the anatomical localization of memory subsets in other species
(Seder and Ahmed, 2003).
Early migration studies employing adoptive transfer and
lymph canulation experiments in sheep, described memory T
cells as constantly recirculating cells that patrol through periph-
eral tissues including the skin and intestinal mucosa (Gowans and
Knight, 1964; Cahill et al., 1977; Mackay et al., 1990, 1992). These
seminal studies along with more recent work using parabiotic
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systems in mice, have led to the concept that blood-borne mem-
ory cells frequently exchange with their counterparts in lym-
phoid and most extra-lymphoid or peripheral tissues (Butcher
and Picker, 1996; Von Andrian and Mackay, 2000), although
exceptions for some epithelial and neuronal tissues with lim-
ited exchange between blood and tissue cells have been noted
(Klonowski et al., 2004). Consistent with the subset-specific
expression of migration receptors, peripheral tissues almost
exclusively contain CD62L− cells which, at face value, appear to
fit into the TEM category (Masopust et al., 2004). Lymph nodes
however, harbor both CD62L+ and CD62L− memory cells, albeit
showing a strong bias toward TCM cells (Sprent and Surh, 2002)
that are likely to have entered the lymph nodes from the blood by
extravasating through high endothelial venules in a CD62L- and
CCR7-dependent fashion (Gallatin et al., 1983; Warnock et al.,
1998; Forster et al., 1999). The minor fraction of CD62L− cells
found in lymph nodes instead may be comprised of classical TEM
cells that return from peripheral tissues via afferent lymphatics
(Mackay et al., 1990, 1992).
Interestingly, while CCR7 is critically involved in T cell hom-
ing to lymph nodes via high endothelial venules (Forster et al.,
1999), its expression is also required for efficient T cell entry into
afferent lymphatic vessels in peripheral tissues (Bromley et al.,
2005; Debes et al., 2005). This raises the important question
as to whether peripheral TEM cells dynamically regulate CCR7
expression during tissue exit and/or whether there may exist dis-
tinct populations of peripheral T cells with varying abilities to
return to the circulation depending on their expression levels of
CCR7 and their responsiveness to locally produced chemokines
(Bromley et al., 2005). Regardless, it appears that the delineation
of T cell memory into TCM and TEM subsets based on CD62L
and CCR7 expression, may not reflect the full complexity of
chemokine receptor usage in T cell recirculation that has now
emerged from animal studies. Furthermore, recently described
populations of non-migratory memory T cells in peripheral tis-
sues that exist in disequilibrium with the circulating T cell pool,
do not easily fit this widely used classification of T cell memory
subsets.
IMMUNE PROTECTION BY CIRCULATING CD8+ MEMORY
T CELLS
Memory T cells differ from their naïve counterparts by their
persistence at elevated frequencies, their broader anatomical
distribution and their ability to rapidly acquire effector func-
tions upon reactivation (Kaech et al., 2002). As a consequence,
they are regarded as powerful mediators of immune protec-
tion from reinfection. In keeping with this, protective immunity
by CD8+ memory T cells has been demonstrated in various
experimental models of systemic infection, such as Listeria mono-
cytogenes, lymphocytic choriomeningitis virus (LCMV), and the
malaria parasite Plasmodium berghei (Bachmann et al., 1997,
2005; Wherry et al., 2003; Badovinac et al., 2005; Huster et al.,
2006; Schmidt et al., 2008). Importantly, T cell immunity in
these cases of systemic infection is long-lived and can be con-
ferred to naïve animals by the adoptive transfer of pathogen-
specific CD8+ memory T cells (Lau et al., 1994). Thus, it appears
that persisting antigen is not required for the maintenance
of functional CD8+ T cell memory that is able to control
lymphoid replication and systemic dissemination of various
pathogens.
MEMORY T CELL MIGRATION AND PERIPHERAL IMMUNE
SURVEILLANCE
In contrast to their role in immune protection from systemic
infections, the ability of circulating CD8+ memory T cells to deal
with localized infections in the periphery is surprisingly limited
(Bachmann et al., 1997, 2005; Jiang et al., 2012; Mackay et al.,
2012a). This lack of peripheral protection by circulating memory
T cells, seen across a variety of models, is best explained by their
progressive loss of peripheral migration abilities (Kundig et al.,
1996; Bachmann et al., 1997; Woodland and Kohlmeier, 2009).
Consistent with this, effector or early memory T cells in the cir-
culation gradually lose expression of homing molecules required
to enter peripheral tissues (Masopust et al., 2010; Gebhardt
et al., 2011). In addition, the population of circulating TEM
cells appears to decline over time, resulting in a progressive
conversion of the memory cell pool toward a CD62L+ TCM phe-
notype (Tripp et al., 1995; Wherry et al., 2003). Collectively,
these changes result in a skewing of the overall pattern of mem-
ory T cell recirculation from peripheral, non-lymphoid organs
early after infection toward secondary lymphoid organs in the
absence of continued antigenic stimulation (Gebhardt et al., 2011;
Yang et al., 2011). Interestingly, this shift in migratory prefer-
ence is most pronounced in the CD8+ T cell subset, whereas
CD4+ T cells appear to retain their ability to migrate through
peripheral tissues including the skin and intestinal mucosa, for
prolonged periods of time (Gebhardt et al., 2011; Yang et al.,
2011). In line with this, CD4+ memory T cells predominate
among the population of peripheral cells returning to the circula-
tion via afferent lymphatics in both sheep and humans (Mackay
et al., 1990; Yawalkar et al., 2003). Taken together, it appears
that continuous antigenic stimulation is essential for optimal
migratory immune surveillance by CD8+ memory T cells, but
not for their CD4+ counterparts. This requirement obviously
poses significant challenges for the development of future vac-
cines targeting CD8+ T cell memory. Along these lines, recent
studies have shown that ongoing T cell activation by persist-
ing vaccine vectors is necessary for long-lived mucosal immunity
against SIV infection in non-human primates (Hansen et al.,
2009, 2011), highlighting the requirement for persisting anti-
genic stimulation to sustain ongoing peripheral CD8+ T cell
surveillance.
PERMANENTLY TISSUE-RESIDENT CD8+ MEMORY
T (TRM) CELLS
Despite the progressive loss of circulating TEM cells with periph-
eral migration abilities, extra-lymphoid tissues including the
intestinal and vaginal mucosa, skin, brain, salivary glands, and
several others can harbor substantial populations of long-lived
pathogen-specific CD8+ memory T cells (Table 1) (Bevan, 2011;
Sheridan and Lefrancois, 2011; Ariotti et al., 2012). Of note, such
cells are often localized to epithelial or neuronal tissues, mean-
ing that their access to lymphatic vessels, located in the respective
non-epithelial or non-neuronal compartments, is restricted by
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Table 1 | Examples of mouse models describing peripheral CD8+ memory T cells that fit the recent definition of CD103+ TRM cells.
Category Mode of lodgment Location of TRM cells References
Virus infection Influenza virus infection (i.c.) Brain Hawke et al., 1998
Lymphocytic choriomeningitis
virus infection
Intestinal and vaginal mucosa, brain,
kidney, gastric mucosa, pancreas, and
salivary glands
Masopust et al., 2006, 2010; Hofmann
and Pircher, 2011; Casey et al., 2012
Vesicular stomatitis virus
infection
Brain, salivary glands, and intestinal
mucosa
Masopust et al., 2004; Klonowski et al.,
2004; Wakim et al., 2010; Hofmann and
Pircher, 2011
Herpes simplex virus infection Skin, dorsal root ganglia, and vaginal
mucosa
Gebhardt et al., 2009, 2011; Tang and
Rosenthal, 2010
Vaccinia virus infection Skin and intestinal mucosa Isakov et al., 2009; Jiang et al., 2012
Non-specific local inflammation DNFB treatment Skin Mackay et al., 2012a
Nonoxynol-9 treatment Vaginal mucosa Mackay et al., 2012a
Local antigen presentation Intracranial injection of
peptide-pulsed DC
Brain Wakim et al., 2010
Non-specific T cell activation Lymphopenia-driven T cell
activation
Intestinal and vaginal mucosa, brain,
kidney, gastric mucosa, pancreas, and
salivary glands
Casey et al., 2012
Abbreviations: i.c., intracranial; DNFB, 1-fluoro-2,4-dinitrobenzene; DC, dendritic cells.
structural barriers such as basement membranes and the blood
brain barrier, respectively. A common feature of CD8+ memory
T cells in epithelial and neuronal tissues is their expression of
high levels of CD103, the α-chain of the αEβ7 integrin, CD49a,
the α-chain of the α1β1 integrin [very late antigen (VLA-1)], and
CD69, a surface molecule typically found on recently activated
T cells. Interestingly, dendritic epidermal γδ T cells (DETC) in
mouse skin, as well as other types of non-conventional T cells
in epithelial tissues also express high levels of CD103 and CD69
(Ibraghimov and Lynch, 1994; Lefrancois et al., 1994; Jameson
et al., 2004). This suggests that microenvironmental factors in
these niches may be responsible for the sustained expression of
high levels of these molecules on T cells. While naïve CD8+ T cells
express intermediate levels of CD103, effector and resting mem-
ory T cells in the circulation lack expression of both CD103 and
CD69 (Lefrancois et al., 1994; Masopust et al., 2006; Gebhardt
et al., 2009). This noticeable phenotypic difference led to the
hypothesis that circulating and peripheral memory T cells may
represent distinct populations that show minimal, if any, inter-
mixing with each other (Ibraghimov and Lynch, 1994; Masopust
and Lefrancois, 2003). As discussed below, there is now com-
pelling evidence that peripheral CD8+ CD103+ memory T cells
indeed represent a non-migratory population of cells that are
maintained without replenishment from the circulating memory
T cell pool. Emphasizing these unique features, these cells are
now widely referred to as tissue-resident memory T (TRM) cells
(Bevan, 2011; Di Meglio et al., 2011; Sheridan and Lefrancois,
2011; Ariotti et al., 2012).
ANIMAL MODELS DESCRIBING CD103+ TRM CELLS
Skin infection with herpes simplex virus (HSV)-1 generates a
population of CD8+ CD103+ TRM cells in the epidermal layer of
the skin that persist at elevated frequencies for more than a year
after initial lodgment. Interestingly, these cells are concentrated
at sites of previous infection or inflammation, while remote
areas of skin harbor only low numbers of these cells (Figure 1A)
(Gebhardt et al., 2009; Mackay et al., 2012a). Intravital imag-
ing experiments have demonstrated that epidermal TRM cells
have an irregular shape with a dendritic morphology (Gebhardt
et al., 2011) and thereby resemble other immune cell types
present in the same location including DETC and Langerhans
cells. Consistent with their site-specific accumulation and per-
sistence, epidermal TRM cells show only very restricted local
migration and minimal displacement over time. Notably, this
behavior is in stark contrast to the rapid movement seen for
CD4+ memory T cells which, in contrast to CD8+ T cells,
mainly localize to the dermal layer of the skin (Gebhardt et al.,
2011).
Similar populations of persisting CD8+ TRM cells have been
described following virus infection of the brain and submandibu-
lar glands (Hawke et al., 1998; Wakim et al., 2010; Hofmann and
Pircher, 2011), and intracranial labeling experiments have indi-
cated that clusters of neuronal TRM cells are retained in areas
of previous infection for at least several weeks (Wakim et al.,
2010). Such results are in line with the observation that intestinal
infection generates a distinct population of virus-specific epithe-
lial CD8+ memory T cells that differs from their counterparts
in the lamina propria or the spleen in terms of T cell recep-
tor rearrangement and usage (Isakov et al., 2009). Interestingly,
TRM cells isolated from the brain or gut show impaired sur-
vival and defective recall proliferative responses upon transfer
into the circulation of recipient mice (Masopust et al., 2006;
Isakov et al., 2009; Wakim et al., 2010). Thus, TRM cells may
irreversibly adapt to their local environments and therefore, may
require a constant supply of microenvironment-specific factors
for long-term survival and optimal functionality.
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FIGURE 1 | Local differentiation and persistence of TRM cells. (A)
Localized infection or inflammation of the skin generates a population of
epidermal CD103+ TRM cells that exist in disequilibrium with their
counterparts in the circulation. High numbers of TRM cells are concentrated
at sites of previous infection or inflammation, whereas remote areas of skin
contain only low numbers of these cells. (B) Effector CD8+ T cells that have
infiltrated infected skin can undergo three principal fates. While the majority
of cells are likely to (i) die in situ, others may (ii) egress the skin in a
CCR7-depdendent fashion and join the evolving pool of circulating memory
T cells. A minority of cells may (iii) access the epidermal layer of the skin
where they can undergo TGF-β-dependent differentiation into TRM cells
during the resolution phase of infection. (C) The role of local antigen
recognition in TRM-differentiation is dependent on anatomical location. While
peripheral tissues such as skin and intestinal mucosa can promote
TRM-differentiation in the absence of local antigenic stimulation, the same
process in neuronal tissues such as brain and ganglia requires local antigenic
T cell restimulation. The basement membrane in the skin and the
blood-brain-barrier in the brain sequester TRM cells from the circulation.
The most definitive pieces of evidence for the disequilib-
rium between TRM and circulating memory T cells stem from
experiments employing parabiotic mice (Klonowski et al., 2004;
Jiang et al., 2012), tissue transplantation (Gebhardt et al., 2009;
Masopust et al., 2010), and pharmacological blockade of T cell
recirculation (Masopust et al., 2010; Jiang et al., 2012). In addi-
tion, experiments involving the transfer ofmale T cells into female
recipients have demonstrated the long-term survival of epidermal
TRM cells even in the face of an anti-male histoincompatibility
response that results in the rapid rejection of circulating T cells
(Gebhardt et al., 2011). Collectively, these studies demonstrate
that circulating memory CD8+ T cells have only very limited
access to epithelial and neuronal compartments in the steady
state. Instead, these anatomical niches are permanently occu-
pied by an autonomous population of non-migratory TRM cells
that are characterized by the expression of a unique pattern of
adhesion and migration molecules (Table 2).
Non-migratory peripheral cells may also exist amongst the
pool of CD4+ memory T cells (Cauley et al., 2002; Clark et al.,
2006). For instance, a recent report has described a population of
lung-seeking CD69+ CD11a+ memory CD4+ T cells that were
retained in the lung parenchyma for at least 3 weeks in para-
biotic mice (Teijaro et al., 2011), although others have reported
a progressive decline of virus-specific CD4+ memory T cells in
the same location (Cauley et al., 2002). A similar population of
lung-resident CD4+ memory T cells with a distinct phenotype
has also been described in human lungs (Purwar et al., 2011), and
given that these cells were enriched for influenza virus-specific
cells, it appears likely that these cells play an important role
in early local protection from reinfection (Hogan et al., 2001b;
Purwar et al., 2011). While in previously HSV-infected mouse
skin almost all CD8+ memory T cells have hallmark features
of TRM cells, including epidermal localization and expression
of high levels of CD103 (Gebhardt et al., 2011), the pool of
peripheral CD4+ memory T cells in the skin and other periph-
eral organs may be considerably more heterogeneous. This is
supported by the observation that virus-specific CD4+ memory
T cells consist of both CD103− and CD103int populations in
previously infected skin (Gebhardt et al., 2011). Some of these
cells may represent truly recirculating cells in transit through
the periphery, as indicated by lymph canulation studies (Mackay
et al., 1990; Yawalkar et al., 2003), whereas others might be
retained in extralymphoid locations for prolonged periods of
Table 2 | Phenotypic differences between CD8+ memory T cell
subsets.
Category Marker TCM TEM TRM
Migration/adhesion CD62L ++ − −
CCR7 ++ ± −
CD44 ++ ++ +++
CD69 − − ++
CD103 − − +++
E-cadherin − − +
VLA-1 ± ± ++
ESLa, PSLa ++ /− − +++
Survival CD122 ++ + +
CD127 ++ + +
Bcl-2 ++ ++ ++
Effector function Granzyme B − + +
aShown only for skin TRM cells.
Abbreviations: ESL, E-selectin ligands; PSL, P-selectin ligands.
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time (Teijaro et al., 2011). Further studies will have to clar-
ify whether such cells are indeed permanently resident within
peripheral tissues and, if so, whether similar mechanisms are
involved in the long-term persistence of both CD4+ and CD8+
T cells subsets.
HUMAN CD8+ CD103+ MEMORY T CELLS WITH CHARACTERISTICS
OF TRM CELLS
The expression of CD103 defines a heterogeneous population
of intraepithelial T cells in skin and mucosal tissues that exist
in many species including rodents and humans (Parker et al.,
1992; Agace et al., 2000). Intraepithelial populations of T cells
comprise non-conventional T cells expressing CD8α:α homod-
imers and/or γδ T cells, as well as conventional CD8α:β αβ T cells
(Lefrancois et al., 1994; Hayday et al., 2001). While these cells are
present in many tissues under normal physiological conditions,
a marked accumulation of the CD8+ CD103+αβ T cell subset is
often associated with localized immune phenomena in epithelial
and neuronal compartments, including graft rejection (Hadley
et al., 1999; Wong et al., 2003), chronic inflammation (Ebert
et al., 1998), infection (Piet et al., 2011), tumor development
(Ling et al., 2007; Masson et al., 2007; Webb et al., 2010), and
autoimmune processes (Pauls et al., 2001; Mizukawa et al., 2002;
Teraki and Shiohara, 2002). Intriguingly, there is accumulating
evidence that such populations of human T cells share major
characteristics with the TRM cells described in mouse experi-
ments, including their long-term persistence and expression of
TRM signature markers such as CD69 and VLA-1, in addition
to CD103.
Psoriasis is a chronic inflammatory skin disease characterized
by well-demarcated erythematous plaques that tend to reoccur
in identical anatomical locations on cessation of therapy (Nestle
et al., 2009). Of note, psoriatic lesions are characterized by the
accumulation of epidermal CD8+ CD103+ CD69+ memory T
cells (Pauls et al., 2001; Teraki and Shiohara, 2002). Most strik-
ingly, studies using xeno-transplantation of healed skin onto
immuno-compromised mice have shown that these cells can
locally persist for several weeks after transplantation, and that
their activation by as yet unknown antigens results in the VLA-1-
dependent local reappearance of psoriatic lesions (Boyman et al.,
2004; Conrad et al., 2007). Another example for the contribu-
tion of resident T cells to localized skin pathology is the so-
called fixed drug eruption, an allergic skin reaction with sharply
demarcated lesions that are triggered by the ingestion of certain
drugs. Interestingly, lesion development is characterized by the
rapid activation of epidermal CD8+ CD103+ memory T cells
(Mizukawa et al., 2002). Of note, these lesions strictly reoccur
in identical anatomical regions even several years after the last
exposure to the disease-causing drug, implicating long-term sur-
vival of locally resident memory cells (Mizukawa et al., 2008).
Furthermore, predilection sites for lesions are often areas of skin
that have previously been exposed to some form of tissue trauma
or infection (Mizukawa and Shiohara, 2002), thereby resem-
bling the requirements for optimal TRM cell lodgment described
in mouse experiments (Gebhardt et al., 2009; Mackay et al.,
2012a). Other examples of TRM cells in humans include influenza
virus-specific CD8+ CD103+ T cells that persist in the alveolar
epithelium of the lungs (Piet et al., 2011), as well as virus-
specific CD8+ memory T cells that are preferentially retained
in close proximity to the epidermis and peripheral nerves fol-
lowing HSV-2 infection in vaginal skin (Zhu et al., 2007, 2009).
In addition, Epstein-Barr virus-specific CD8+ CD103+ T cells
have been detected at high frequencies in the tonsils of persis-
tently infected individuals (Hislop et al., 2005; Woodberry et al.,
2005). Collectively, these studies strongly suggest that perma-
nently tissue-resident T cells equivalent to the CD8+ CD103+
TRM cells defined inmice, also exist in humans. Importantly, these
cells appear to play a significant role in local infection control and
various types of immuno-pathologies.
LOCAL DIFFERENTIATION AND PERSISTENCE OF CD103+
TRM CELLS
Several lines of evidence indicate that the local differentiation of
TRM cells occurs early during the resolution phase of infection.
For instance, circulating effector cells rapidly lose the ability to
infiltrate epithelial tissues and form TRM cells (Masopust et al.,
2010; Mackay et al., 2012a). Moreover, substantial populations of
male-derived TRM cells can lodge in female recipient mice even
in the face of a potent anti-male rejection response that results
in the rapid elimination of virtually all effector cells from the
circulation (Gebhardt et al., 2011). These results further sug-
gest that cells capable of differentiating into TRM cells must exist
amongst the effector cells that infiltrate peripheral tissues at the
early stages of infection. Following pathogen clearance, these
effector cells may undergo three fundamentally different fates
(Figure 1B). While the majority of cells are likely to undergo
apoptotic cell death in situ, others may enter afferent lymphat-
ics in a CCR7-dependent manner and return to the circulation
where they can join the evolving pool of circulating memory cells
(Brown et al., 2010; Jennrich et al., 2012). Aminority of cells how-
ever, may access epithelial compartments and further differentiate
into long-lived TRM cells. Given that T cell receptor-dependent
activation can reduce the responsiveness of effector T cells toward
CCR7 ligands (Debes et al., 2004; Schaeuble et al., 2011; Jennrich
et al., 2012), it is possible that local antigen recognition, although
not strictly required (Casey et al., 2012;Mackay et al., 2012a), sup-
ports effector T cell retention and further TRM cell differentiation.
While commitment to either of these fates could be a stochastic
process, it is tempting to speculate that the ability to differentiate
into either circulating memory or TRM cells may be specific traits
of distinct committed precursor cells. Future studies will have to
establish the nature of TRM precursor cells and will also have to
better define the environmental cues that support their differ-
entiation into TRM cells. Such insights may help to determine
optimal conditions for the generation of high densities of TRM
cells, critical for the development of T cell-based future vaccines,
as discussed below.
THE ROLE OF ANTIGEN DEPENDS ON ANATOMICAL LOCATION
The molecular mechanisms that underlie the generation and
long-term persistence of TRM cells remain largely unknown.
However, recent studies have begun to shed some light on the
basic requirements for the establishment of peripheral TRM-
cell populations. Although T cells typically require antigenic
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activation in order to infiltrate peripheral sites, their subsequent
differentiation into TRM cells in extralymphoid tissues does not
require ongoing stimulation (Figure 1C). Non-specific inflam-
mation alone for instance is sufficient to generate a substantial
population of TRM cells that locally persist for more than a
year (Mackay et al., 2012a). Remarkably, even lymphopenia-
driven activation following transfer of transgenic T cells into
lymphocyte-deficient mice results in the generation of TRM pop-
ulations in a broad variety of peripheral organs (Casey et al.,
2012). Exceptions to this, however, are neuronal tissues such
as the brain and dorsal root ganglia (DRG) where local recog-
nition of cognate antigen is required for CD103 induction in
CD8+ T cells (Figure 1C) (Wakim et al., 2010; Casey et al.,
2012; Mackay et al., 2012a). Interestingly, even the intracranial
injection of peptide-pulsed dendritic cells is sufficient to gener-
ate a local population of TRM cells in the brain (Wakim et al.,
2010). The additional level of “specificity control” in neuronal
tissues may represent a mechanism to restrict the lodgment of
potentially autoaggressive T cells, which could have detrimental
consequences in the face of the inherently limited regenerative
capacity of these organs. This further suggests that autocrine fac-
tors produced by the T cells themselves are involved in these
specific locations, whereas other tissues such as the epidermis
and the intestinal epithelium may promote TRM differentiation
through the provision of such factors in a more promiscuous and
paracrine manner.
THE ROLE OF TRANSFORMING GROWTH FACTOR-β
Transforming growth factor (TGF)-β induces CD103 expression
in activated rodent and human T cells (Kilshaw and Murant,
1990; Cepek et al., 1993). Accordingly, epithelial T cells express-
ing a dominant negative form of the TGF-β receptor show
impaired upregulation of CD103 in vivo. This has been demon-
strated in several experimental models including intestinal graft-
versus-host disease, pulmonary influenza virus infection and
lymphopenia-driven induction of intestinal epithelial T cells
(El-Asady et al., 2005; Lee et al., 2011; Casey et al., 2012).
Thus, TGF-β-mediated signals play a critical role for CD103
induction during TRM differentiation in various body locations
(Figure 1B). Nevertheless, it remains possible that other local
factors are necessary to drive and sustain the remarkably ele-
vated levels of CD103 expression seen particularly for epithelial
T cells such as TRM cells and DETC. Several cell types includ-
ing fibroblasts, mast cells, T cells as well as keratinocytes and
enterocytes can be potent sources of TGF-β, particularly during
the regenerative wound-healing phase of the immune response
(Li et al., 2006). In addition, epithelial injury results in the
upregulation of the integrin αvβ6 (Breuss et al., 1995) that is
involved in the local conversion of latent TGF-β into its bio-
logically active form (Li et al., 2006). For instance, cutaneous
wounding induces αvβ6 expression selectively in keratinocytes
surrounding the wound edges (Breuss et al., 1995), which sug-
gests that these cells may be involved in providing and converting
active TGF-β for the induction of CD103 in differentiating TRM
cells. The assumption that epithelial accumulation of CD103+
T cells is a consequence of local induction rather than selec-
tive recruitment of CD103+ cells is further supported by the
observation that effector cells can readily access epithelial and
neuronal sites in the absence of CD103 expression and that,
in fact, the vast majority of early infiltrating cells lack expres-
sion of this integrin subunit (Wakim et al., 2010; Mackay et al.,
2012a).
THE ROLE OF THE αEβ7 INTEGRIN
CD103, the α-chain of the αEβ7 integrin, is one of the signa-
ture markers for CD8+ TRM cells and functions as a receptor
for E-cadherin, an adhesion molecule specifically expressed by
epithelial cells (Cepek et al., 1993, 1994). While some effector
CD8+ T cells express killer lectin receptor G1 (KLRG1), which
is another E-cadherin binding molecule (Grundemann et al.,
2006), the expression of this molecule is usually absent from TRM
cells (Masopust et al., 2006; Wakim et al., 2010; Hofmann and
Pircher, 2011). Intestinal epithelial T cells and DETC can use
CD103 to adhere and interact with enterocytes and keratinocytes,
respectively (Cepek et al., 1993, 1994; Schlickum et al., 2008). In
line with this, CD103-deficient mice have reduced numbers of
these T cells (Schon et al., 1999, 2002; Schlickum et al., 2008),
although residual populations are still present even in the absence
of CD103. Furthermore, virus-, tumor-, or alloantigen-specific
CD8+ TRM cells deficient in CD103 expression show impaired
persistence in the brain, lung and the intestinal epithelium (El-
Asady et al., 2005; Masson et al., 2007; Wakim et al., 2010; Lee
et al., 2011; Casey et al., 2012). These results implicate a func-
tional role for CD103 in the local differentiation and long-term
persistence of TRM cells in various epithelial and neuronal tis-
sues, although the requirement of CD103 may not be absolute
(Lefrancois et al., 1999). Interestingly, TRM cells themselves also
express E-cadherin and this molecule is involved in optimal per-
sistence of virus-specific TRM cells in salivary glands (Hofmann
and Pircher, 2011). While binding of CD103 to E-cadherin is
likely to promote local retention by tethering T cells to neighbor-
ing epithelial cells, other modes of action apart from this adhesive
function have also been proposed. These include the regulation
of T cell proliferation and cytolytic effector function, but possibly
also extend to the functional modulation of epithelial and T cells
as a result of E-cadherin ligation by T cell-derived CD103 (Agace
et al., 2000). Moreover, CD103+ TRM cells in the brain express
higher levels of the anti-apoptotic molecule Bcl-2 in comparison
to CD103− cells isolated from the same location, implicating a
role for outside-in signaling through CD103 in promoting TRM
cell survival (Wakim et al., 2010). This mechanism may be of
particular importance given that TRM cells show only minimal
homeostatic turnover when compared to lymphoid CD8+ mem-
ory T cells (Masopust et al., 2006; Gebhardt et al., 2009; Wakim
et al., 2010), indicating that the maintenance of the TRM pool is
mainly regulated by their longevity rather than through constant
self-renewal. Consistent with this, TRM cells show only low-level
expression of CD122 (Masopust et al., 2006; Gebhardt et al., 2009;
Wakim et al., 2010), the receptor for interleukin (IL)-15 known to
drive homeostatic turnover in lymphoid CD8+ memory T cells
(Surh and Sprent, 2008), and it has been suggested that CD8+
memory T cells can be maintained independently of IL-15 signals
following mucosal, as in contrast to systemic infections (Verbist
et al., 2011).
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THE PUTATIVE ROLE OF OTHER ADHESION AND MIGRATION
MOLECULES
Apart from CD103, TRM cells also express a number of other
adhesion and migration molecules that are likely to be involved
in their local retention. These include the α1β1 integrin (VLA-1),
CD44, ligands for E- and P-selectins, and the chemokine recep-
tor CCR9, although expression of some of these molecules may
be specific for TRM populations in certain organs (Table 2). TRM
cells in the epidermis and the salivary glands express high levels
of VLA-1 (Gebhardt et al., 2009; Hofmann and Pircher, 2011),
a receptor for the extracellular matrix (ECM) proteins collagen
type I and IV (Ben-Horin and Bank, 2004), the latter of which
is a major structural component of basement membranes. Of
note, VLA-1+ influenza virus-specific CD8+ memory T cells in
the lung localize to collagen-rich areas in close association to
airways, blood vessels and alveoli, and genetic VLA-1 deficiency
or antibody-mediated blockade of VLA-1 function results in
strongly reduced numbers of these cells (Ray et al., 2004). It is still
under debate as to whether lung-resident CD8+ memory T cells
share major characteristics such as longevity and permanent res-
idency with their counterparts in other extralymphoid tissues
(Takamura et al., 2010; Lee et al., 2011), and this matter is further
complicated by inherent technical difficulties in identifying bona
fide tissue-resident as in contrast to intravascular T cells in this
particular organ (Anderson et al., 2012). Regardless, these results
nevertheless suggest that TRM cells in other organsmay also utilize
the VLA-1 integrin for their adhesion to basement membranes
in epithelial compartments. In a similar fashion, CD44, which is
expressed at very high levels on TRM cells (Gebhardt, unpublished
results), may also be involved in local retention through its inter-
action with hyaluronic acid, a major ECM component abundantly
expressed in epithelial tissues (Baaten et al., 2012). Furthermore,
epidermal TRM cells express remarkably high levels of ligands for
E- and P-selectins (Jiang et al., 2012), which represent a hetero-
geneous group of modified glycoproteins including CD44, CD43,
PSGL-1, and possibly others (Woodland and Kohlmeier, 2009).
While these molecules play a major role in skin migration of
effector and memory T cells through their binding to E- and P-
selectin on endothelial cells in the cutaneous microvasculature
(Agace, 2006), skin TRM cells may further utilize such receptors
to bind to as yet unidentified ligands constitutively expressed in
the epidermis. Finally, TRM cells can also express organ-specific
chemokine receptors that enable them to respond to gradients
of locally produced chemokines. One example of this is the sus-
tained expression of CCR9 by gut-resident TRM cells (Masopust
et al., 2010), which is the receptor for the chemokine CCL25, con-
stitutively expressed by enterocytes in the small intestine (Agace,
2006). Interestingly, another adhesionmolecule critically involved
in gut migration by virus-specific effector CD8+ T cells, the inte-
grin α4β7 that binds to the mucosal addressin MAdCAM-1 on
blood vessels (Williams and Butcher, 1997; Lefrancois et al., 1999;
Agace, 2006), is rapidly lost in intestinal T cells on epithelial
entry (Masopust et al., 2010), and therefore, does not seem to be
involved in local persistence of gut TRM cells.
Future studies will have to clarify the precise contribution of
the aforementioned adhesion andmigration receptors to the local
retention and persistence of TRM cells in different anatomical
locations. Experimental approaches targeting selected candidate
molecules, however, could be complicated by the possibility that
many of these molecules may exert redundant or overlapping
functions. Furthermore, in addition to their function in tethering
TRM cells to their microenvironments, several of these molecules
have also been implicated in outside-in signaling in T cells, mean-
ing that their ligation by ECM components may directly impact
on cellular functions including long-term survival or the expres-
sion of preformed effector molecules such as granzyme B (Agace
et al., 2000; Richter and Topham, 2007; Baaten et al., 2012). In line
with this, TRM cell express high levels of the activation marker
CD69 even in the absence of cognate antigen (Masopust et al.,
2006; Gebhardt et al., 2009), possibly reflecting some level of cel-
lular activation maintained by their prolonged interaction with
various microenvironmental stimuli.
LOCAL IMMUNITY BY TRM CELLS
While circulating memory T cells provide efficient protection
against systemic infections that result in rapid accumulation of
pathogens in lymphoid filter organs, their ability to deal with
localized infections in the periphery is often limited. This defi-
ciency is partly explained by their progressive loss of peripheral
migration as well as by their delayed accumulation at periph-
eral sites of infection due to the time-consuming nature of T cell
recruitment from the circulation. Instead, it has been proposed
that memory T cells already residing in peripheral tissues at the
time of infection—either permanently as in the case of TRM cells,
or temporarily as proposed for CD4+ memory T cells—are key to
rapid infection control in barrier tissues such as skin and mucosa
(Woodland and Kohlmeier, 2009; Di Meglio et al., 2011; Kupper,
2012; Masopust and Picker, 2012).
Importantly, memory CD8+ T cells isolated from the intesti-
nal mucosa exhibit enhanced effector function such as rapid
interferon (IFN)-γ production and target cell lysis following res-
timulation ex vivo (Masopust et al., 2001). Similarly, TRM cells
isolated from the brain and skin can rapidly reacquire effec-
tor functions and kill peptide-pulsed target cells in situ and
ex vivo, respectively (Hawke et al., 1998; Wakim et al., 2010; Jiang
et al., 2012). Our own unpublished results further indicate that
virus-specific TRM cells produce IFN-γ within the first 24 h after
epidermal or mucosal infection with HSV-1. Such results demon-
strate that TRM cells indeed display the full arsenal of effector
functions required for immediate local immune control at sites
of peripheral infection.
CONTROL OF LOW-LEVEL PERSISTENT AND LATENT VIRUS
INFECTIONS
As discussed above, peripheral infections leave behind a popu-
lation of TRM cells concentrated at sites of previous pathogen
encounter. The reason why these cells are formed particularly in
epithelial and neuronal tissues sequestered away from the circula-
tion is not entirely clear. It is tempting to speculate, however, that
their main evolutionary purpose is to deal with residual, chronic
or latent reservoirs of pathogens. Of note, circulating CD4+ and
CD8+ memory T cells are largely excluded from epithelial and
neuronal tissues under non-inflammatory conditions (Klonowski
et al., 2004; Gebhardt et al., 2011). Thus, in the absence of locally
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persisting TRM cells, such tissues would be highly vulnerable to
pathogens that specifically target these sites to establish locally
persisting or latent reservoirs in the absence of overt inflamma-
tion (Zinkernagel, 2002), as seen in infections with HSV, varicella
zoster virus, and human papilloma virus.
Epithelial HSV infection in the skin or vaginal mucosa results
in the establishment of a latent infection that is restricted to sen-
sory ganglia innervating the site of primary infection. This latent
infection is characterized by the absence of both infectious viral
particles and ongoing inflammation (Stanberry, 1992; Sawtell,
1997) and therefore escapes immuno-surveillance by circulating
CD8+ memory T cells (Himmelein et al., 2011). However, TRM
cells selectively retained within infected ganglia (Khanna et al.,
2003) can recognize latently infected neurons and control viral
latency through non-cytolytic mechanisms including the site-
directed release of effector molecules such as granzyme B (Van
Lint et al., 2005; Knickelbein et al., 2008; Mackay et al., 2012b).
Interestingly, these ganglionic TRM cells retain their full function-
ality even in the face of chronic antigenic stimulation and can
readily produce effector cytokines and mount local proliferative
recall responses on experimental virus reactivation (Wakim et al.,
2008; Mackay et al., 2012b). Importantly, similar populations of
HSV-specific CD8+ T cells are also retained in latently infected
ganglia in humans (Verjans et al., 2007), and further accumulate
at sites of anticipated virus reemergence such as the sensory nerve
endings and epidermis of previously HSV-2-infected human vagi-
nal skin (Zhu et al., 2007, 2009).
PROTECTION FROM VIRUS REINFECTION
The local persistence of TRM cells at sites of previous infection or
inflammation can be interpreted as a strategy of the immune sys-
tem to predict or anticipate the site of reencounter with the same
or similar pathogens (Bevan, 2011). This is best documented for
skin infection, where levels of site-specific immunity in previ-
ously infected areas of skin can be compared with control skin not
involved in the primary infection. Indeed, following localized skin
infection with HSV-1 in B cell-deficient mice, there is strongly
enhanced local protection from virus reinfection specifically at
the site of previous infection harboring elevated numbers of TRM
cells (Gebhardt et al., 2009). Furthermore, following reconstitu-
tion of lymphocyte-deficient mice with virus-specific CD8+ T
cells, TRM cells can mediate site-specific immunity alone, in the
absence of virus-specific antibodies and CD4+ memory T cells
(Gebhardt et al., 2009). Importantly, this form of local immu-
nity is long-lived and can be observed for at least 3 months after
primary immunization (Gebhardt et al., 2009), which is con-
sistent with the remarkable longevity of TRM cells. Confirming
these results, TRM cells generated in skin and salivary glands after
vaccinia or LCMV infection, respectively, mediate potent protec-
tion from rechallenge infection even when T cell recirculation is
pharmacologically inhibited by treatment with the sphingosine-
1-phosphate antagonist FTY720 (Liu et al., 2009; Hofmann and
Pircher, 2011; Jiang et al., 2012). Similarly, memory T cells in the
lung can contribute to local immunity (Hogan et al., 2001a; Ray
et al., 2004), although protection from heterosubtypic reinfection
in this location appears to wane with time (Liang et al., 1994),
which is potentially related to the fact the lung environment is
not as conducive to support TRM cell survival as other barrier tis-
sues (Woodland and Kohlmeier, 2009). Collectively, these results
strongly support the notion that TRM cells at body surfaces play
a major role in protection from localized reinfection, whereas
circulating CD8+ memory T cells may be specialized in dealing
with pathogens that access lymphoid tissues following systemic
infection.
PROTECTION FROM de novo INFECTION—TRM CELLS AS VACCINE
TARGETS
The induction of long-livedmemory T cells able to patrol through
peripheral tissues has proven difficult in the absence of contin-
ued T cell activation (Kundig et al., 1996; Bachmann et al., 1997;
Hansen et al., 2009). However, TRM cells do not rely on persisting
antigen (Casey et al., 2012; Mackay et al., 2012a), and as a conse-
quence, targeting these cells with novel vaccination strategies has
the potential to overcome obstacles originating from the progres-
sive loss of peripheral immune surveillance by circulating CD8+
memory T cells. Given that TRM cells can mediate rapid immune
control at peripheral sites of infection, the generation of high den-
sities of such cells is an appealing goal for future vaccines against
pathogens that invade the body via peripheral portals of entry.
Strategically well-positioned at peripheral sites, TRM cells may
provide a first line of defense potent enough to control peripheral
infection before local pathogen replication results in the estab-
lishment of chronic or latent reservoirs as seen in infections such
as HSV and human immunodeficiency virus. We have recently
shown that the combination of T cell activation and site-specific
lodgment by non-specific inflammation generates high densities
of long-lived TRM cells in the skin and these that cells are able to
(1) control local virus replication, (2) prevent viral skin disease,
and (3) significantly reduce the ensuing latent infection in DRG
innervating the site of de novo challenge infection (Mackay et al.,
2012a). While this approach provides regional rather than global
protection of the skin, it has recently been suggested that repeated
immunization in prime-boost settings can generate high densities
of TRM cells even in remote areas of skin not involved in successive
immunization steps (Jiang et al., 2012) (Figure 2). Furthermore,
non-specific inflammation of the vaginal mucosa has been shown
to result in the local accumulation of TRM cells capable of control-
ling a subsequent infection with HSV-1 (Mackay et al., 2012a). Of
note, the latter approach represents an example where coverage of
a whole organ system, the cervico-vaginal mucosa, is achievable
by a single intervention without the need of repeated immu-
nizations. Collectively, these results provide promising proof-of-
principle evidence that TRM cells may successfully be exploited
in vaccination settings. Future studies are needed to refine the
requirements for optimal TRM lodgment and coverage of different
organ systems. Finally, complementing such innovative immu-
nization strategies with the simultaneous induction of other
adaptive immune elements, including tissue-tropic CD4+ mem-
ory T cells and antibody-secreting plasma cells, has the potential
to further enhance protection afforded by TRM cells.
CONCLUDING REMARKS
To a large extent, the field of T cell memory has been dominated
by the paradigm that memory T cells are constantly recirculating
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FIGURE 2 | Local immunity by site-specific or global lodgment of
TRM cells. (A) High numbers of TRM cells can be generated in the
skin by an immunization strategy that combines the induction of
effector T cells with the local application of an inflammatory
stimulus. This results in potent local immunity at the targeted site.
(B) Repeated immunizations in different skin sites result in elevated
numbers of TRM cells in both targeted and remote areas of skin.
This strategy has the potential to generate global TRM-cell-mediated
immunity against skin infection, although this remains to be formally
proven.
cells that patrol through either lymphoid or extralymphoid tis-
sues as a consequence of subset-specific migratory programs. An
important extension to this concept is that these fundamentally
different migration patterns correlate with the functional status
exhibited by distinct memory subsets, and thereby, predict their
participation in different types of immune responses. Recent evi-
dence based on the analysis of antigen-specific memory T cells
in various lymphoid and non-lymphoid tissues, however, sug-
gests that a large proportion of peripheral CD8+ memory T cells
are permanently sessile and non-migratory and therefore, do
not easily fit into the prevailing concept of circulatory immune
surveillance. Given that these TRM cells show remarkable similari-
ties in terms of the expression of core signature markers, residency
and effector function irrespective of their mode of generation
and localization to different peripheral organs, it is tempting to
speculate that TRM differentiation represents a default pathway of
CD8+ memory T cell generation in non-lymphoid tissues. Their
important role in infection control highlights the need to better
understand the molecular mechanisms that govern their differ-
entiation and long-term persistence in peripheral sites. Future
studies will also have to clarify whether similar populations of
non-migratory peripheral cells also exist among the pool of CD4+
memory T cells. Refining the contribution of circulating versus
permanently tissue-resident populations of memory T cells to
immune protection in barrier tissues such as the skin and mucosa
will be critical to the design of future immunization strategies
harnessing cellular immunity to protect against pathogens that
invade through peripheral portals of entry.
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